Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends
A review of evolving trends in third line treatment of advanced gastric cancer shows sequential treatment approaches benefit a growing minority of... Read More
Dr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer
Dr. Syma Iqbal, Keck School of Medicine at University of Southern California, discusses second- and third-line therapies in gastric cancer via OncLive.
Implications of FGF 2 Amplification for GI Cancer Treatment
Watch this new video on the implications of fibroblast growth factor (FGF) 2 amplification for GI Cancer Treatment.
A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation
Scientists test a risk-scoring mode for developing lymph node metastasis that can guide and personalize treatment for patients with early gastric cancer.
Gastroesophageal Cancer: Initial Approaches
What is different among gastric cancer treatment guidelines in the United States, Europe, and Japan? Watch in OncLive.
Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Good results from the drug Lonsurf for treating metastatic gastric cancer in a phase 3 trial are being presented this week at... Read More
